Latest News & Features
Americas
New president says repeal is first of “many steps the US federal government will take to repair our institutions and our economy” | Defunct order aimed to lower drug costs and place caps on essential medications | Big Pharma argues higher drug prices are necessary to fund R&D for new therapies. 21 January 2025
Unified Patent Court
UK trade association weighs in on Microsoft UPC appeal which deals with issue of representation | Former CIPA head says court should not “divide” European patent profession | SMEs could be forced to opt out patents due to counsel costs. 21 January 2025
Big Pharma
A district court of appeal has paused MSN Pharmaceuticals’ launch | Result comes days after the Federal Circuit restored Novartis’ patent and overturned a decision in favour of MSN | Request is one in a flurry of filings between the pair over the heart-failure drug. 16 January 2025
Careers
Partner plus team of four patent attorneys and four paralegals join Munich office | Firm says the addition strengthens its position in German and international markets. 16 January 2025
Europe
New analysis examines funding gap for European startups and where to find investment | UK’s active VC market bucks trend in Europe where tech funding largely driven by public programmes. 16 January 2025
Careers
Ex-Corrs Chambers Westgarth pharma specialist joins firm’s growing litigation practice. 16 January 2025
Careers
IP specialist joins firm’s Bristol office | Transaction expert has advised AstraZeneca, Cancer Research Horizons, and other high-profile clients. 14 January 2025
Big Pharma
Federal circuit reverses district court’s ruling to revive combination patent | Novartis says patent has paediatric exclusivity expiring in July 2025. 14 January 2025
Europe
Company faces setback as EPO revokes patent for a C1-esterase inhibitor treatment | Patent aims at preventing antibody-mediated rejection in kidney transplant patients | Court cites insufficient clinical trial data. 9 January 2025
Careers
Skilled in microbiome, medical devices and next generation diagnostics, the new partner is skilled in creating IP strategies for startups, spinouts and SMEs. 9 January 2025